Global Immuno-oncology Market Projected at $ 396 Billion by 2034 with a 22.94% CAGR; Asia Pacific to Witness Fastest Growth
09 févr. 2024 07h42 HE
|
Research and Markets
Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Immuno-oncology Market" report has been added to ResearchAndMarkets.com's offering.The global immuno-oncology market size was estimated to be...
Global Cancer Immunotherapy Market to Reach $188.11 Billion by 2030, Propelled by Innovative Treatments and Rising Incidence Rates
05 févr. 2024 04h21 HE
|
Research and Markets
Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report...
Immuno-Oncology Market Poised for Substantial Growth, Driven by Advanced Technologies and Biomarker Integration
31 janv. 2024 08h10 HE
|
Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
Tumor Infiltrating Lymphocytes Industry Projected to Reach $18.32 Billion by 2028 - Emerging Technologies, such as cytoDRIVE, and Strategic Alliances Propelling the Global Market Forward
23 janv. 2024 09h43 HE
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Tumor Infiltrating Lymphocytes Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Growth Driven by...
$7.25 Bn Antibody Fragments Markets - Global Industry Size, Share, Trends, Opportunity, and Forecasts to 2028
15 janv. 2024 08h58 HE
|
Research and Markets
Dublin, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The "Antibody Fragments Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ...
Provectus Biopharmaceuticals Announces Notice of Allowance of First U.S. Patent of Rose Bengal Sodium for Use as Anticancer and Antiviral Vaccine Adjuvant
18 déc. 2023 08h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (USPTO) has allowed patent application 17/488,430, titled...
Cancer Immunotherapy Market to Reach USD 251.41 Billion By 2032 | Emergen Research
11 déc. 2023 07h48 HE
|
Emergen Research
Vancouver, Dec. 11, 2023 (GLOBE NEWSWIRE) -- The global Cancer Immunotherapy Market size was USD 84.53 Billion in 2021 and is expected to register a revenue CAGR of 10.4% during the forecast period,...
ImmunOs Therapeutics Presents Details of Novel Bispecific Anti-Tumor Molecules at ESMO Immuno-Oncology Congress 2023
11 déc. 2023 04h00 HE
|
AKAMPION
HLA/SIRPa bispecifics targeting LILRB1/2 plus CD47 checkpoint receptorDesigned to target myeloid, NK and T cells and to be precisely directed to tumor sitesPotent in vitro anti-tumor efficacy...
Evaxion Presents Proof-of-Principle for Its Unique AI Model Predicting Responses to Cancer Immunotherapy
15 nov. 2023 08h00 HE
|
Evaxion Biotech
Evaxion today presents a novel AI model designed to predict patient responses to standard-of-care cancer immunotherapyThe model demonstrates promising potential for improving patient outcomes,...
Provectus Biopharmaceuticals Provides Updated Data on Cancer Immunotherapy PV-10 for Metastatic Uveal Melanoma
13 nov. 2023 08h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today provided updated data from an ongoing Phase 1 clinical trial of investigational cancer immunotherapy PV-10 (rose bengal...